Discovery of Natural Kv1.3 Channel Inhibitors From Furanocoumarins of Angelica dahurica via Integrative Computational Screening and Electrophysiological Validation
Chemistry & Biodiversity · 2026-11 · 23 (11)
DOI: 10.1002/cbdv.71923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 14.11.2026. Verfasst von Yujie Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, Laboratory of Anti-aller…. Hauptthemen laut MEDLINE: Kv1.3 Potassium Channel, Furocoumarins, Angelica, Potassium Channel Blockers. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the cooperation agreement between Zhejiang Sci-Tech University and Hangzhou Zheda Dixun Bio-Genetic Engineering Co., Ltd.
Abstract (Originalsprache)
The voltage‐gated potassium channel Kv1.3 regulates T‐cell activation and is a therapeutic target for autoimmune and inflammatory diseases. Although synthetic inhibitors such as PAP‐1 show potent activity, natural‐product alternatives remain underexplored. Angelica dahurica is rich in furanocoumarins and has anti‐inflammatory effects, thus, we investigated its constituents as Kv1.3 inhibitors. A library of 43 A. dahurica furanocoumarins was screened using molecular docking and MM/GBSA calculations against Kv1.3 (PDB: 7SSX). Eight compounds, representing four matched C‐5/C‐8‐substituted pairs, were selected based on screening results and availability for electrophysiological validation. Whole‐cell patch‐clamp recordings in human embryonic kidney 293 (HEK‐293) cells showed that all eight compounds inhibited Kv1.3 currents, with IC 50 values of 4.27–22.42 µM. Three of the four matched pairs showed greater inhibitory potency for the C‐5‐substituted analogue, suggesting a preference for C‐5 substitution. At 10 µM, cell viability remained above 80% for CPD‐1 (bergamottin), CPD‐3 (cnidilin), and CPD‐4 (phellopterin) in both L929 fibroblasts and RAW 264.7 macrophages. Furthermore, molecular dynamics simulations indicated stable binding of CPD‐1 and CPD‐3 to Kv1.3, supported by RMSD, RMSF, and protein–ligand interaction profiles. These findings identify CPD‐1 and CPD‐3 as promising Kv1.3 inhibitors and support further investigation of A. dahurica furanocoumarins as lead compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, Laboratory of Anti-allergy Functional Molecules, College of Life Sciences and Medicine, Zhejia…
- State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Nabeel Khalid Bhutta, Bingnan Han
Förderung
- National Natural Science Foundation of China
- the cooperation agreement between Zhejiang Sci-Tech University and Hangzhou Zheda Dixun Bio-Genetic Engineering Co., Ltd
Zitieren
APA
Chen, Y., Sha, Y., Zhao, X., Lei, B., Guan, L., Bhutta, N. K., Zhang, F., & Han, B. (2026). Discovery of Natural Kv1.3 Channel Inhibitors From Furanocoumarins of Angelica dahurica via Integrative Computational Screening and Electrophysiological Validation. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71923
Vancouver
Chen Y, Sha Y, Zhao X, Lei B, Guan L, Bhutta NK, et al. Discovery of Natural Kv1.3 Channel Inhibitors From Furanocoumarins of Angelica dahurica via Integrative Computational Screening and Electrophysiological Validation. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71923
BibTeX
@article{Chen2026,
author = {Chen, Yujie and Sha, Yueshi and Zhao, Xianya and Lei, Binglin and Guan, Liyang and Bhutta, Nabeel Khalid and Zhang, Fan and Han, Bingnan},
title = {Discovery of Natural Kv1.3 Channel Inhibitors From Furanocoumarins of Angelica dahurica via Integrative Computational Screening and Electrophysiological Validation},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {11},
doi = {10.1002/cbdv.71923}
}
EUVIMED